Back to Search
GEORGE BLUMENSCHEIN, M.D.
M.D.
Medical Oncology Physician
NPI: 1346334125IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
K4304(TX)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
UNIVERSITY OF TEXAS MEDICAL SCHOOL AT HOUSTON
Class of 1994
Research & Publications (20)
Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer.
PMID 19652055·J Clin Oncol·2009
3-trial
Phase III trial comparing carboplatin, paclitaxel, and bexarotene with carboplatin and paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT II.
PMID 18398153·J Clin Oncol·2008
3-trial
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
PMID 17960324·Invest New Drugs·2008
3-trial
Sorafenib in lung cancer: clinical developments and future directions.
PMID 18520294·J Thorac Oncol·2008
6-review
Angiogenesis inhibitors for lung cancer: clinical developments and future directions.
PMID 17409952·J Thorac Oncol·2006
6-review
Integration of targeted therapies in gemcitabine chemotherapy regimens.
PMID 14624709·Clin Lung Cancer·2003
8-other
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
PMID 19515503·Int J Radiat Oncol Biol Phys·2010
8-other
Durable response to chemotherapy for recurrent squamous cell carcinoma of the cheek with perineural spread.
PMID 19667357·Arch Ophthalmol·2009
5-case
Summary statement novel agents in the treatment of lung cancer: Fifth Cambridge Conference assessing opportunities for combination therapy.
PMID 18520291·J Thorac Oncol·2008
8-other
Tumor cavitation during therapy with antiangiogenesis agents in patients with lung cancer.
PMID 18379352·J Thorac Oncol·2008
8-other
Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
PMID 18289332·Int J Dermatol·2008
5-case
Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
PMID 18059220·Am J Surg Pathol·2007
8-other
Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
PMID 17418967·Int J Radiat Oncol Biol Phys·2007
4-observational
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.
PMID 16640804·Clin Lung Cancer·2006
4-observational
Epidermal growth factor receptor inhibitors in development for the treatment of non-small cell lung cancer.
PMID 16857825·Clin Cancer Res·2006
6-review
Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma.
PMID 16342067·Cancer·2006
8-other
Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer.
PMID 16301597·J Clin Oncol·2005
3-trial
Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer.
PMID 16258975·Cancer·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1346334125
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 32
- Publications
- 20
Are you this provider?
Claim Your Profile